This study is closed and no longer accepting participants.
You’re invited to participate in an exciting clinical trial opportunity for the atopic dermatitis community. Leo Pharma is running a phase 2 trial to evaluate the safety and effectiveness of an orally-administered tablet.
In order to qualify, you must be:
- Diagnosed with atopic dermatitis (eczema)
- 18 years or older
- Living in the U.S. or Australia
- Willing to take an oral tablet for up to 4 months
Please note that all study-related costs, including those associated with travel to the study clinic, will be reimbursed – you can speak with your site coordinator to learn more about the details.